Interruption de service

En raison de travaux de maintenance électrique à l'IDRIS, le site de la SFBI sera inaccessible du 27 au 29 mars 2023.

Bioinformatician in charge of the discovery of tumor biomarkers

 CDD · IE  · 6 mois (renouvelable)    Bac+5 / Master   I2BC, CNRS, Université Paris-Saclay, CEA · Gif sur Yvette (France)

 Date de prise de poste : 10 avril 2023


Cancer RNA-seq oncogenomics transcriptomics immunogenomics


Researchers from the I2BC (Gif sur Yvette) and Curie Institute are collaborating on a project aiming to identify tumor-specific biomarkers from expression data (RNA-seq). We are looking for a bioinformatician to take part in this project with an initial 6-month contract. This is a unique opportunity to join a multidisciplinary team across I2BC and Curie Institute, an ambitious scientific project at its early days, aiming to transition towards a company set up in the near term.

The bioinformatician will be in charge of implementing new RNA-seq analysis methods to identify markers in large tumor datasets. This is a core activity of the project, for which the candidate will work in a team with bioinformaticians and biologists from the partner labs, in direct contact with a professor and group leader at I2BC

Specific activities:

- Development and deployment of original RNA-seq analysis pipelines

- NGS data indexing and querying

- Functional analysis of RNA lists

- Writing documentation and presenting results to scientists and non-scientists


We are looking for high level candidates capable of performing analyses while mastering the biological objectives.

Candidates should have a Master's degree, engineering degree or thesis in bioinformatics, with demonstrated experience in human NGS data analysis and pipeline development. A strong collaborative mindset is required. Experience in oncogenomics, algorithms or NGS data structures would be an added advantage.



Procédure : Send CV to

Date limite : 3 avril 2023


Daniel Gautheret

Offre publiée le 14 mars 2023, affichage jusqu'au 10 avril 2023